Skip to main content

Table 1 Changes in the refractive power and axial length in the right eyes of the different groups (mean ± SD)

From: The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia

 

Refractive power(D, n = 10)

Axial length(mm, n = 10)

Time

NC

FDM

FDM + AT

F

P

NC

FDM

FDM + AT

F

P

0 weeks

2.700 ± 1.657

2.65 ± 1.688

2.575 ± 1.555

0.015

0.985

7.595 ± 0.116

7.608 ± 0.114

7.610 ± 0.101

0.054

0.947

2 weeks

1.600 ± 1.425#

-0.075 ± 1.616*

1.425 ± 1.486#

3.712

0.038

7.782 ± 0.099###

8.005 ± 0.102***

7.791 ± 0.095###

16.415

0.000

4 weeks

0.850 ± 1.385###

-2.450 ± 0.956***

-0.025 ± 1.502###

17.228

0.000

7.890 ± 0.084###

8.272 ± 0.087***

7.921 ± 0.107###

51.664

0.000

F

3.878

30.645

7.399

  

22.079

107.888

23.834

  

P

0.033

0.000

0.003

  

0.000

0.000

0.000

  
  1. Compared with the NC group at the same time point,*P < 0.05, **P < 0.01, ***P < 0.001. Compared with the FDM group at the same time point,#P < 0.05, ##P < 0.01, ###P < 0.001